Reply to Cimolai: Post-COVID syndrome and autoimmunity

J Infect Dis. 2022 Sep 4;226(4):753-754. doi: 10.1093/infdis/jiac106.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Autoantibodies
  • Autoimmune Diseases*
  • Autoimmunity
  • COVID-19*
  • Humans
  • Lymphocyte Activation

Substances

  • Autoantibodies